 DNA vaccines are a promising treatment for infectious diseases and cancer. The ideal delivery method for induction of cellular and humoral immune responses has not been defined. Information from this study is necessary for future studies using Derma VaxTrademark in therapeutic DNA vaccine studies. Derma VaxTrademark is unique in its proprieties of delivering a series of electric pulses that provoke DNA uptake by antigen presenting cells that reside in the dermal layer of the skin. We expect that the application of Intradermal Electroporation IDEP using Derma VaxTrademark will be well tolerated and the use of EMLARegistered Trademark cream will decrease the pain compared to placebo. 